Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Metastases in Prostate Cancer.
Manna F, Karkampouna S, Zoni E, De Menna M, Hensel J, Thalmann GN, Kruithof-de Julio M. Manna F, et al. Among authors: de menna m. Cold Spring Harb Perspect Med. 2019 Mar 1;9(3):a033688. doi: 10.1101/cshperspect.a033688. Cold Spring Harb Perspect Med. 2019. PMID: 29661810 Free PMC article. Review.
X-rays effects on cytoskeleton mechanics of healthy and tumor cells.
Panzetta V, De Menna M, Musella I, Pugliese M, Quarto M, Netti PA, Fusco S. Panzetta V, et al. Among authors: de menna m. Cytoskeleton (Hoboken). 2017 Jan;74(1):40-52. doi: 10.1002/cm.21334. Epub 2016 Aug 31. Cytoskeleton (Hoboken). 2017. PMID: 27533498
Erratum: Metastases in Prostate Cancer.
La Manna F, Karkampouna S, Zoni E, De Menna M, Hensel J, Thalmann GN, Kruithof-de Julio M. La Manna F, et al. Among authors: de menna m. Cold Spring Harb Perspect Med. 2018 Jul 2;8(7):a035568. doi: 10.1101/cshperspect.a035568. Cold Spring Harb Perspect Med. 2018. PMID: 29967098 Free PMC article. No abstract available.
A NF-ĸB-Activin A signaling axis enhances prostate cancer metastasis.
Chen L, De Menna M, Groenewoud A, Thalmann GN, Kruithof-de Julio M, Snaar-Jagalska BE. Chen L, et al. Among authors: de menna m. Oncogene. 2020 Feb;39(8):1634-1651. doi: 10.1038/s41388-019-1103-0. Epub 2019 Nov 18. Oncogene. 2020. PMID: 31740783
Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity.
La Manna F, De Menna M, Patel N, Karkampouna S, De Filippo MR, Klima I, Kloen P, Beimers L, Thalmann GN, Pelger RCM, Jacinto E, Kruithof-de Julio M. La Manna F, et al. Among authors: de menna m, de filippo mr. Front Oncol. 2020 Jun 23;10:1012. doi: 10.3389/fonc.2020.01012. eCollection 2020. Front Oncol. 2020. PMID: 32656088 Free PMC article.
Patient-derived xenografts and organoids model therapy response in prostate cancer.
Karkampouna S, La Manna F, Benjak A, Kiener M, De Menna M, Zoni E, Grosjean J, Klima I, Garofoli A, Bolis M, Vallerga A, Theurillat JP, De Filippo MR, Genitsch V, Keller D, Booij TH, Stirnimann CU, Eng K, Sboner A, Ng CKY, Piscuoglio S, Gray PC, Spahn M, Rubin MA, Thalmann GN, Kruithof-de Julio M. Karkampouna S, et al. Among authors: de menna m. Nat Commun. 2021 Feb 18;12(1):1117. doi: 10.1038/s41467-021-21300-6. Nat Commun. 2021. PMID: 33602919 Free PMC article.
Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity.
La Manna F, De Menna M, Patel N, Karkampouna S, De Filippo MR, Klima I, Kloen P, Beimers L, Thalmann GN, Pelger RCM, Jacinto E, Kruithof-de Julio M. La Manna F, et al. Among authors: de menna m. Front Oncol. 2021 Feb 3;11:650623. doi: 10.3389/fonc.2021.650623. eCollection 2021. Front Oncol. 2021. PMID: 33614519 Free PMC article.
Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label treatment.
Hirt CK, Booij TH, Grob L, Simmler P, Toussaint NC, Keller D, Taube D, Ludwig V, Goryachkin A, Pauli C, Lenggenhager D, Stekhoven DJ, Stirnimann CU, Endhardt K, Ringnalda F, Villiger L, Siebenhüner A, Karkampouna S, De Menna M, Beshay J, Klett H, Kruithof-de Julio M, Schüler J, Schwank G. Hirt CK, et al. Among authors: de menna m. Cell Genom. 2022 Feb;2(2):100095. doi: 10.1016/j.xgen.2022.100095. Cell Genom. 2022. PMID: 35187519 Free PMC article.
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.
Bianco G, Coto-Llerena M, Gallon J, Kancherla V, Taha-Mehlitz S, Marinucci M, Konantz M, Srivatsa S, Montazeri H, Panebianco F, Tirunagaru VG, De Menna M, Paradiso V, Ercan C, Dahmani A, Montaudon E, Beerenwinkel N, Kruithof-de Julio M, Terracciano LM, Lengerke C, Jeselsohn RM, Doebele RC, Bidard FC, Marangoni E, Ng CKY, Piscuoglio S. Bianco G, et al. Among authors: de menna m. Commun Biol. 2022 Apr 19;5(1):373. doi: 10.1038/s42003-022-03296-x. Commun Biol. 2022. PMID: 35440675 Free PMC article.
21 results